Skip to content

13F-HR filed by Broadfin Capital, LLC

Broadfin Capital, LLC filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-14, with 51 holding rows worth $511,193,000.

Accession
0000919574-13-004769
Filed
2013-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2013

A holdings report, 52 entries on the cover page, a total value of $511,193,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $511,193,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NATUS MEDICAL INC639050103COM2,590,992$35,367,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR863,236$33,839,000thousands by filing date
DEPOMED INC249908104COM5,622,023$31,596,000thousands by filing date
ANGIODYNAMICS INC03475V101COM2,726,651$30,757,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM1,398,543$27,884,000thousands by filing date
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM1,983,442$26,653,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM1,696,754$25,638,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM1,822,258$21,703,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON3,139,131$19,268,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW502,914$18,422,000thousands by filing date
ALKERMES PLCG01767105SHS600,000$17,208,000thousands by filing date
PROGENICS PHARMACEUTICALS IN743187106COM3,500,615$15,613,000thousands by filing date
EMERGENT BIOSOLUTIONS INC29089Q105COM1,074,248$15,491,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK800,000$13,305,000thousands by filing date
CEMPRA INC15130J109COM1,555,147$12,083,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01775,000$10,346,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK3,050,000$10,187,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK1,428,314$10,041,000thousands by filing date
ANACOR PHARMACEUTICALS INC032420101COM1,724,028$9,637,000thousands by filing date
ARTHROCARE CORP043136100COM265,585$9,171,000thousands by filing date
HI-TECH PHARMACAL CO INC42840B101COMMON STOCK273,232$9,071,000thousands by filing date
SOLTA MED INC83438K103COM3,928,135$8,956,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM2,122,054$8,616,000thousands by filing date
ATRICURE INC04963C209COM791,841$7,522,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM250,000$6,725,000thousands by filing date
DURECT CORP266605104COM5,999,100$6,299,000thousands by filing date
MASIMO CORP COM574795100Stock250,837$5,318,000thousands by filing date
CARDICA INC14141R101COM4,385,715$4,868,000thousands by filing date
VENTRUS BIOSCIENCES INC922822101COM1,849,839$4,440,000thousands by filing date
GLOBUS MED INC CL A379577208Stock248,767$4,194,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK300,000$4,152,000thousands by filing date
MERIT MED SYS INC COM589889104Stock333,734$3,721,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock291,740$3,489,000thousands by filing date
QLT INC746927102COMMON STOCK784,893$3,446,000thousands by filing date
INTELLIPHARMACEUTICS INTERNA458173101CMN1,960,779$3,333,000thousands by filing date
TRIUS THERAPEUTICS INC89685K100COM404,427$3,276,000thousands by filing date
POZEN INC73941U102COMMON STOCK641,000$3,211,000thousands by filing date
DURATA THERAPEUTICS INC26658A107COM383,227$2,759,000thousands by filing date
SPECTRANETICS CORP84760C107COM138,720$2,591,000thousands by filing date
DISCOVERY LABORATORIES INC N254668403COM NEW1,666,000$2,532,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS280,000$2,467,000thousands by filing date
PAIN THERAPEUTICS INC69562K100COM1,000,000$2,210,000thousands by filing date
ANTHERA PHARMACEUTICALS INC03674U102COM4,200,000$1,945,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM500,000$1,940,000thousands by filing date
BIODEL INC09064M204COM459,771$1,922,000thousands by filing date
ROCKWELL MED INC774374102COM528,065$1,906,000thousands by filing date
CUTERA INC232109108COM215,962$1,900,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM117,172$1,897,000thousands by filing date
ZOGENIX INC98978L105COM1,068,493$1,827,000thousands by filing date
CAS MED SYS INC124769209COM220,544$368,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR3,000$83,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-13-004769this filing2013-08-14acceptance time not in the bulk data set